An interventional study of Submaximal cycle ergometer test-retest in Osteo Arthritis Knee and Hip, sponsored by Vastra Gotaland Region. Recruiting at 1 site in Sweden. Open to participants aged 30 Years and older. Per ClinicalTrials.gov, last updated 2026-08-20.
Sponsored by Vastra Gotaland Region · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 10 studies in Osteoarthritis, Knee by Vastra Gotaland Region — 3 open to participants now, 6 under way, none of them phase 3. Osteoarthritis, Knee · Vastra Gotaland Region.
Among the 10 studies in Osteoarthritis, Knee by Vastra Gotaland Region, this one is one of 2 that started in 2026, is one of 7 with no phase, and was the 10th registered.
3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.
Browse Osteoarthritis, Knee studies →3 of the 10 studies in Osteoarthritis, Knee by Vastra Gotaland Region are open now, in 1 country. Recruiting first, the newest first:
Vastra Gotaland Region · Sites in Sweden
Ages 18+
Vastra Gotaland Region
Ages 18+
By country, each count listing its studies:
Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.
This study: 30 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
10 studies; the count open now beside each. This study's row is marked.
First in 2013; this study’s year is marked. 2 started in 2026.
This study's planned enrollment of 40 is below the median of 68 across 2,719 interventional studies indexed under Osteoarthritis, Knee.
Median enrollment 138 across the 7 interventional studies, 16 across the 3 observational. Of the 4 that completed or were terminated, 2 (50%) have results posted.
This tab as a report to print or save as PDF → With an account.
Vastra Gotaland Region is the lead sponsor of 276 studies on the registry; 110 are open to participants now.
3 of the studies in Osteoarthritis, Knee by Vastra Gotaland Region that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07212920Vastra Gotaland RegionValidity and Reliability of Video-Based Functional Physiotherapy Assessment of Subacute Knee Injuries | 2026-12-31 |
| NCT05584410Vastra Gotaland RegionDigitalization of Osteoarthritis Care | 2026-12-31 |
| NCT07383740Vastra Gotaland RegionTest-Retest Reliability of a Submaximal Exercise Test in Patients With Hip and Knee Osteoarthritis | 2027-09-01 |
Add all 3 to your calendar (.ics) → With an account.
Among the 10 studies in Osteoarthritis, Knee by Vastra Gotaland Region, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The aim is to evaluate the test-retest reliability of the primary care-adapted Ekblom-Bak submaximal ergometer bicycle test in patients with hip- and/or knee osteoarthritis (OA).
Forty patients with hip- and/or knee OA eligible for the Swedish national OA treatment program in primary care are to be recruited. After screening for contraindications, participants will perform the aEB-test twice within 1-2 weeks.
The investigators hypothezise that the test will demonstrate acceptable test-retest reliability in patients with hip- and/or knee OA.
To establish reliability is essential for future studies using this test in this population and may support its integration into routine clinical assessment.
3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.
This study's planned enrollment of 40 is below the median of 68 across 2,719 interventional studies indexed under Osteoarthritis, Knee.
Browse Osteoarthritis, Knee studies →Vastra Gotaland Region is the lead sponsor of 276 studies on the registry; 110 are open to participants now.
Compared within Osteoarthritis, Knee, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Osteoarthritis. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Forty patients with hip or knee osteoarthritis on the waiting list for usual rehabilitation care will be recruited. The patientes will be screened for contraindications, and, if eligible, will complete a submaximal cycle ergometer test twice within one week.
Procedure: Submaximal cycle ergometer test-retest
Performing a submaximal cycle ergometer test twice
Estimated VO2-max value.
An estimated VO2-max value is obtained by performing the Ekblom Bak submaximal cycle ergometer test.
Time frame: Time between first and second submaximal cycle ergometer test should be one week.
Plan to share: No
Started Apr 2026 (actual). Primary completion is estimated for Sep 2027, 16 months after the start.
Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 16 months is below that.
Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.